Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001363585-13-000016)

Filing Details

Accession Number:
0001363585-13-000016
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-20 16:00:16
Reporting Period:
2013-06-18
Filing Date:
2013-06-20
Accepted Time:
2013-06-20 16:00:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1059784 Generex Biotechnology Corp GNBT Pharmaceutical Preparations (2834) 820490211
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1363585 Stephen Fellows 555 Richmond Street West, Po Box 200
Suite 604
Toronto A6 M5V3B1		 Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-06-18 2,524,164 $0.04 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares sold were acquired by the reporting person on June 6, 2013 upon exercise of options to purchase 2,524,164 shares of the issuer's common stock which were granted by the Board of Directors on March 5, 2013 and June 4, 2013 in lieu of cash payment of deferred compensation. The option grants were effective upon the reporting person's execution of Settlement and Release Agreements with the issuer on April 1, 2013 and June 6, 2013, respectively. The option grants were made pursuant to the terms of the issuer's 2006 stock plan.